Viewing Study NCT00003568


Ignite Creation Date: 2025-12-24 @ 5:34 PM
Ignite Modification Date: 2026-01-03 @ 7:57 AM
Study NCT ID: NCT00003568
Status: COMPLETED
Last Update Posted: 2013-06-26
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma
Sponsor: University of Illinois at Chicago
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma (Skin) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IV melanoma View
None recurrent melanoma View